How Much Per Person? Roundup Settlement Amounts 2026: How Much Will You Get Per Person?

This is the question almost everyone arrives with, so here it is first. Your estimated payout depends mainly on three things: whether you were exposed to Roundup at work or at home, how old you were when you were diagnosed, and whether your non-Hodgkin lymphoma is fast-growing or slow-growing. Those factors place each claim into one of nine tiers, and a claim score then adjusts the tier average up or down by as much as 20 percent based on your medical treatment and the strength of your exposure proof.

Two special funds can add to a base award. The Extraordinary Circumstances Fund provides extra payments for the most serious outcomes — death before age 78, an organ transplant, CAR-T cell therapy, intrathecal chemotherapy, or a Stage IV diagnosis — and draws on up to 5 percent of each annual payment. The Extraordinary Residential Exposure Fund adds money for home users with unusually heavy exposure (defined as 80 or more hours of use across properties totaling six or more acres) and draws on 1.5 percent of each annual payment, with documentary proof required.

Quick Answers to the Top Questions

What’s the average payout per person?

There is no single guaranteed average, and estimates differ. Some analyses of the new deal put the typical claim somewhere around $96,000, while the older 2020 Roundup program averaged closer to $160,000 per plaintiff. Your individual amount could land anywhere from $150 to roughly $198,000 depending on your tier and claim score, so treat any “average” as a rough midpoint, not a promise.

Who qualifies?

In general, anyone in the U.S. who used or was exposed to Roundup before February 17, 2026, met the minimum exposure (16 hours or 10 lifetime days), and was diagnosed with non-Hodgkin lymphoma. Future claimants who used Roundup but are not yet sick are also included. See the full eligibility criteria below.

Do you need to have cancer?

To be included in the settlement class, no — people who used Roundup but have not been diagnosed are automatically covered as “future claimants.” But to actually receive a payout, you must have an NHL diagnosis, either now or within the settlement’s coverage window.

Is the money taxable?

Compensation for a physical illness like cancer is generally not taxable under federal law, but portions tied to lost wages, interest, or punitive damages can be. See the tax section for the framework, and talk to a tax professional about your specific award.

When do you get paid?

Not immediately. The settlement needs final approval at a July 9, 2026 hearing, the fund pays out over roughly 17 to 21 years, and a separate Supreme Court case is still pending. Realistic check timing depends on all three. See the timeline.

The $7.25 Billion Settlement Explained

On February 17, 2026, Bayer — Monsanto’s parent company since 2018 — filed a proposed $7.25 billion class-action settlement in the 22nd Judicial Circuit Court in St. Louis, Missouri. According to Bayer‘s own statements and the official settlement notice, the deal is designed to resolve both current and future non-Hodgkin lymphoma claims tied to the weed killer’s active ingredient, glyphosate. Bayer does not admit that Roundup causes cancer and maintains the product is safe.

Rather than one lump sum, Monsanto would fund the settlement through capped annual payments spread over roughly 17 to 21 years — a structure the company frames as long-term support for people who may be diagnosed years from now, and that critics frame as a way to stretch out and contain its liability. (For more on how multi-year payouts work, see our guide to structured settlements.) Bayer has already spent more than $11 billion resolving roughly 100,000 earlier Roundup claims, and about 65,000 cases remain pending.

The point and matrix system

Payouts are not split evenly. Each claim is run through a settlement matrix that assigns points based on cancer type and severity, age, how long and how often you used Roundup, your treatment intensity, and whether the person has died. Higher scores land in higher tiers and larger awards; lower scores land in smaller ones. The administrator, BrownGreer PLC, processes claims, and a court-appointed expert handles the scoring and tier assignment. It is, in plain terms, a formula — not a courtroom — that decides most people’s compensation.

Subclass 1 vs. Subclass 2

The settlement splits class members into two groups. Subclass 1 covers current claimants — people already diagnosed with NHL. Subclass 2 covers future claimants — people exposed to Roundup before February 17, 2026, who have not yet been diagnosed. Future claimants are automatically included unless they opt out, can file if they are later diagnosed (within six years of diagnosis or before the 16th annual payment date, whichever comes first), and have their legal rights restored if they are never diagnosed by that point. This is the quietly significant part: millions of Americans who used Roundup for decades are now inside a legal framework without ever signing anything.

Who Qualifies for the Roundup Settlement?

Eligibility comes down to a qualifying cancer, enough documented exposure, and the right timing. The official settlement site, WeedKillerClass.com, lays out the criteria in detail; here is the core of it.

The distinction between occupational and residential exposure drives a lot of the dollar difference. Occupational claimants — farmers, landscapers, groundskeepers, applicators, highway crews — need more than 80 hours of work-related exposure and proof they earned more than half their income (or over $15,000) from that work in at least one year, backed by payroll records, tax returns, or business licenses. Residential claimants who sprayed Roundup on their own lawn, garden, or driveway face a lower bar (16 hours or 10 days) and can often qualify on a sworn statement alone. Occupational tiers pay more because that exposure tends to be heavier and more sustained.

If you can prove you used Roundup but cannot document the minimum exposure time, you are not automatically shut out — you may receive a $150 Limited Proof Award. It is a floor, not a windfall, but it keeps the door open.

What Cancers Qualify?

The settlement centers on non-Hodgkin lymphoma (NHL) and its subtypes. Per the official settlement materials, coverage also extends to any leukemia whose name contains the words “lymphoma,” “lymphocytic,” or “prolymphocytic” — which brings in conditions such as chronic lymphocytic leukemia (CLL) and certain B-cell and T-cell leukemias. Hodgkin lymphoma and unrelated cancers are generally outside the scope of this particular deal. Because the covered-conditions list is precise and occasionally updated, confirm your exact diagnosis against the official list before assuming you do or do not qualify.

How to File a Roundup Settlement Claim

The claims process is administered by BrownGreer PLC through the official site, WeedKillerClass.com (the same notice can be reached by phone at 1-888-403-8201). Claim forms open after the court grants final approval, so the steps below are about getting ready and acting quickly once the window opens.

1. Confirm your diagnosis and exposure. Match your NHL diagnosis and your Roundup use against the eligibility criteria — exposure before February 17, 2026, and at least 16 hours or 10 lifetime days.
2. Gather your proof. Pull together medical records showing your diagnosis and treatment, plus anything documenting exposure: employment or payroll records, business licenses, and purchase history.
3. Don’t panic if you lack receipts. You do not need decades-old Roundup receipts. Residential exposure can often be established by a sworn declaration (attestation), and witness statements or purchase history can help support a claim.
4. Register and submit on time. Once final approval is granted, Subclass 1 members have a limited window — reported as 180 days — to register and file a complete claim package. Future claimants file within six years of a later diagnosis.
5. Get the math checked. Because awards turn on tier and score, it can be worth having a licensed attorney review your claim before you submit. (New to class actions? See our guide on how to file a class action lawsuit.)

Should You Opt Out? (And Why Some Are Objecting)

The settlement is a trade: in exchange for a scheduled payout, class members give up the right to sue Monsanto individually over their Roundup injuries. The opt-out and objection deadline was June 4, 2026 — and that window has now closed. If you did not formally exclude yourself by then, you are generally bound by the settlement if the court approves it (though Subclass 1 members still have a registration period after final approval, and a separate path exists for those who can show their state’s filing deadline has not passed).

Plenty of people pushed back before the deadline. Attorneys representing thousands of plaintiffs have filed objections calling the deal a “sweetheart” arrangement that gives Monsanto too much for too little, and health plans have objected over lien and subrogation rights. The core tension is the trade-off: opting out to sue individually can be far more lucrative — juries have returned Roundup verdicts in the hundreds of millions and even billions of dollars — but it is also slower, costlier, riskier, and now hangs heavily on the outcome of the pending Supreme Court case. Anyone weighing that decision should talk to a licensed attorney rather than guess.

When Will You Get Paid? (Timeline & Schedule)

Honestly, not soon — and the exact timing depends on the court and on the pending appeals. A Missouri judge granted preliminary approval in March 2026, but the deal is not final until after the fairness hearing, where the court decides whether it is “fair, reasonable, and adequate.” Then the multi-year payment schedule begins.

Two wild cards could shift everything: the objectors’ appeal of the June 17 decision to keep the case in Missouri state court, and the Supreme Court ruling. Either could delay the July 9 hearing or change how attractive the settlement looks. The settlement’s 17-to-21-year structure also means most claimants will be paid over time rather than all at once — the same long-horizon dynamic explained in our piece on structured settlements.

Is Roundup Settlement Money Taxable?

The general framework, set by the IRS under Internal Revenue Code §104(a)(2), is that compensatory damages received for a personal physical injury or physical sickness — which a cancer like non-Hodgkin lymphoma is — are generally excluded from gross income, meaning that core compensation is typically not taxed. IRS Publication 4345 explains this in plain language.

The exceptions matter. Punitive damages are always taxable, even in a physical-injury case, and are reported as “Other Income.” Interest on a settlement is taxable. Amounts allocated to lost wages can be taxable depending on the underlying claim, and if you previously deducted medical expenses related to your illness, a portion may be taxable under the tax-benefit rule. Because how a settlement is allocated drives how it is taxed, this is genuinely worth running past a CPA or tax attorney — this article is not tax advice.

The Supreme Court Decision: Why It Could Change Everything

Running alongside the settlement is a separate case that could matter even more: Monsanto Company v. Durnell (No. 24-1068). The Supreme Court granted review on January 16, 2026, and heard oral arguments on April 27, 2026. As of mid-June 2026, the Court has not yet issued its decision, which is expected by the end of its term in late June.

The legal question is narrow but enormous in effect: whether the federal pesticide law known as FIFRA preempts state-law failure-to-warn claims when the EPA has not required a cancer warning. Monsanto argues that because the EPA approved Roundup’s label without a cancer warning, it cannot be sued under state laws demanding one. The case stems from a $1.25 million Missouri verdict, and the Trump administration’s Solicitor General sided with Monsanto. At argument, several justices appeared skeptical of the company’s position, and courtroom observers described the outcome as genuinely close to call.

Here is what each outcome would mean:

• If Monsanto wins: a ruling that FIFRA preempts these claims could largely foreclose present and future state-law warning lawsuits — a serious blow to pending appeals and to anyone who opted out to sue individually.
• If Monsanto loses: plaintiffs’ state-law claims are preserved, which would strengthen the position of opt-outs and could even pressure the settlement’s economics.

The case is separate from the settlement but critical to it, because it shapes the value of the very right that opting out preserves. This is the part of the story most likely to move first, and the moment the ruling drops, its meaning for your options changes. (For how preemption and federal funds play out in another mass-tort context, compare our coverage of the Camp Lejeune lawsuit settlement.)

Latest Roundup Settlement Updates (2026)

This litigation is moving week to week. Here is the dated timeline of what has happened, most recent first.

• June 17, 2026 — Case sent back to state court. A federal judge in St. Louis overruled objectors who wanted the settlement reviewed in federal court (where a different judge had sharply criticized it) and remanded it to Missouri state court, clearing a path toward final approval. Reuters reported the objecting plaintiffs filed a notice of appeal the same day.
• June 4, 2026 — Opt-out and objection deadline passed. Class members can no longer formally exclude themselves from the deal.
• April 27, 2026 — Supreme Court hears Monsanto v. Durnell. Justices pressed Monsanto and the federal government hard on the preemption question; the decision remains pending.
• March 4, 2026 — Preliminary approval granted. Judge Timothy Boyer moved the settlement to the next phase and set a July 9 fairness hearing.
• February 17, 2026 — $7.25 billion settlement filed. Bayer proposed the deal to resolve current and future NHL claims.

The next dates to watch are the Supreme Court ruling (expected within days) and the July 9 fairness hearing — though the objectors’ appeal could push that hearing back.

Frequently Asked Questions

How much is the average Roundup settlement per person?

There is no guaranteed average. Estimates of the new deal cluster around the high tens of thousands to roughly $96,000, while the older 2020 program averaged closer to $160,000. Individual awards range from $150 to about $198,000 depending on tier and claim score.

Who qualifies for the Roundup settlement in 2026?

Generally, U.S. residents exposed to Roundup before February 17, 2026, who used it at least 16 hours or 10 lifetime days and were diagnosed with non-Hodgkin lymphoma. People who used Roundup but are not yet diagnosed are included as future claimants.

Do you need cancer to qualify?

You can be part of the settlement class without a diagnosis, but you can only receive a payout if you have non-Hodgkin lymphoma — now, or within the settlement’s future-claim window.

How much can you get from the $7.25 billion settlement?

Standard program awards average roughly $10,000 to $165,000, reaching about $198,000 after a favorable claim score, plus possible extra money from special funds. A reduced Quick-Pay option runs $6,000 to $14,500.

How does the point system work?

Each claim is scored on factors like cancer type and severity, age, and length and intensity of exposure, then placed in one of nine tiers. The tier average is adjusted between 80% and 120% based on your individual score.

How long does it take to receive a check?

There is no payout until after final approval (the hearing is set for July 9, 2026), and the fund pays out over roughly 17 to 21 years. Pending appeals and the Supreme Court ruling could affect timing.

Is Roundup settlement money taxable?

Compensation for a physical illness like cancer is generally tax-free under IRC §104(a)(2), but punitive damages, interest, and some lost-wage portions can be taxable. Consult a tax professional.

How do I file (or opt out of) a claim?

File through the official administrator at WeedKillerClass.com once claim forms open. The opt-out deadline (June 4, 2026) has already passed, so excluding yourself is generally no longer an option.

What cancers qualify for the Roundup lawsuit?

Non-Hodgkin lymphoma and its subtypes, plus leukemias whose names include “lymphoma,” “lymphocytic,” or “prolymphocytic” (such as CLL). Always confirm your exact diagnosis against the official covered-conditions list.

Can family members file a wrongful-death Roundup claim?

Yes — close family members such as spouses, parents, and children may be able to submit a claim based on a loved one’s exposure and diagnosis. Wrongful-death compensatory damages are also generally treated as non-taxable.

When is the final approval hearing?

The fairness hearing is scheduled for July 9, 2026, though the objectors’ appeal could move it. Verify the current date on the official settlement site before relying on it.

How much Roundup exposure do you need to qualify?

At least 16 hours or 10 lifetime days of use. If you can prove exposure but not the minimum amount, you may still receive a $150 Limited Proof Award.